Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (600)	7/2/2000 12:56:33 AM
From: RCMac	Read Replies (1) \| Respond to of 1834

>> Might the action in NBIX have been Russell 2000 related? << It seems unlikely. NBIX has been on the preliminary list for addition to the R2000 from the beginning (see the current version at russell.com ). NBIX has a market cap of near $800 million, so there’s no reason for anyone to think NBIX might not make the final cut – the threshold is much lower, somewhere in the $200-$250M range, I believe. Whatever caused the dramatic gyration in NBIX, it at least wasn’t a rational reaction to anything to do with R2000. More likely, I’d guess, that some large holder took the opportunity to lighten up or get out during the surge, and panicked some other folks into selling. --RCM